IJCRR - 6(22), November, 2014
EARLY DETERIORATION IN QUALITY OF LIFE AND PHYSICAL FUNCTIONING OF MULTIPLE SCLEROSIS PATIENTS
Author: Ozge Ertekin, Serkan Ozakbas, Egemen Idiman
Objectives: (1) To examine the associations among ambulatory capacity, physical functioning and quality of life (QOL) in multiple sclerosis patients with different disability levels and compare the results to the healthy controls, and (2) to explain the relationship between QOL, disability status and disease duration. Methods: 112 multiple sclerosis patients and 50 healthy controls were selected for the study. Clinical and demographic data were recorded. Disability status (EDSS), walking ability and capacity (MSWS-12, T25FW), physical functioning (SF-36 /PF-10), QOL (MUSIQOL) and disease severity (MSIS-29) were evaluated. Outcome results of two subgroups with mild and moderate ambulatory impairment were analysed and compared with the control group. Results: There were a statistically significant difference between multiple sclerosis patients with low to moderate disability in MSWS-12, T25FW, SF-36 (PF-10) (p<0.001), and MSIS-29 (p=0.018); additionally in the outcome results for EDDS (p<0.001), MSWS-12 (p<0.001), MSIS-29 (p=0.08) according to the physical functioning classification. Conclusions: The clinical impact of disability severity may contribute to impairments in walking, significantly influencing physical functioning in multiple sclerosis patients. QOL impairment may be emerged regardless of the disability level and disease duration.
Keywords: Multiple sclerosis, Disability, Walking, Physical functioning, Quality of life
Ozge Ertekin, Serkan Ozakbas, Egemen Idiman. EARLY DETERIORATION IN QUALITY OF LIFE AND PHYSICAL FUNCTIONING OF MULTIPLE SCLEROSIS PATIENTS International Journal of Current Research and Review. 6(22), November, 29-38
1. Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical ac- Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychol Health Med 2009; 14(1):111-24.
2. Weikert M, Suh Y, Lane A, Sandroff B, Dlugonski D, Fernhall B, et al. Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis. Med Eng Phys. 2012; 34(5): 590-7.
3. Van Asch P. Impact of mobility impairment in multiple sclerosis 2 patient perspectives. Eur Neurol Rev. 2011; 6: 115–20.
4. Heesen C, Bohm J, Reich C, Kasper J, Goebel M, Gold SM. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler. 2008; 14: 988–91.
5. Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. 2012; 18(7): 914-24.
6. Panitch H, Applebee A. Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability. Expert Opin Pharmacother. 2011; 12(10): 1511- 21.
7. Ertekin Ö, Özakba? S, ?diman E. Caregiver Burden, Quality of Life and Walking Ability in Different Disability Levels of Multiple Sclerosis. NeuroRehabilitation 2014; 34: 313-21.
8. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology 1997; 48: 74-8.
9. Chruzander C, Ytterberg C, Gottberg K, Einarsson U, Widén Holmqvist L, Johansson S. A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in health-related quality of life and the value of different factors in predicting healthrelated quality of life.J Neurol Sci. 2014; 15: 339(1-2):57- 63.
10. Paltamaa J, Sarasoja T, Leskinen E, Wikström J, Mälkiä E. Measures of physical functioning predict self-reported performance in self-care, mobility, and domestic life in ambulatory persons with multiple sclerosis. Arch Phys Med Rehabil. 2007; 88: 1649-57.
11. Salter AR, Cutter GR, Tyry T, Marrie RA, Vollmer T. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin. 2010; 26: 493-500.
12. Cavanaugh JT, Gappmaier VO, Dibble LE, Gappmaier E. Ambulatory activity in individuals with multiple sclerosis. J Neurol Phys Ther. 2011; 35(1): 26-33.
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guideliness for reserach protocols. Ann Neurol. 1983; 13: 227-31.
14. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983; 33: 1444-52.
15. Ertekin Ö, Özakbas S, diman E, Algun ZC. Quality of Life, Fatigue and Balance Improvements after Home-Based Exercise Programme in Multiple Sclerosis Patients. Archives of Neuropsychiatry. 2012; 49 (1): 33-8.
16. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology. 2003; 60: 31-6.
17. Gijbels D, Dalgas U, Romberg A, de Groot V, Bethoux F, Vaney C, et al. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult Scler. 2012; 18 (3): 364-71.
18. Koçyiit H, Aydemir Ö, Fi?ek G, Ölmez N, Memi A. K?sa Form-36 (KF-36)’nn Türkçe versiyonunun güvenilirli?i ve geçerlili?i. ?laç ve Tedavi Dergisi. 1999; 12: 102-6.
19. Nogueira LA, Nóbrega FR, Lopes KN, Thuler LC, Alvarenga RM. The effect of functional limitations and fatigue on the quality of life in people with multiple sclerosis. Arq Neuropsiquiatr. 2009; 67(3B): 812-7.
20. Simeoni MC, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Constantinescu CS, et al, on behalf of the MUSIQOL study group. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler. 2008; 14(2): 219-23.
21. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001; 124(Pt 5), 962-73.
22. Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler. 2006; 12: 620-8.
23. Dalgas U, Kjølhede T, Gijbels D, Romberg A, Santoyo C, de Noordhout BM, et al. Aerobic intensity and pacing pattern during the six-minute walk test in patients with multiple sclerosis. J Rehabil Med. 2014; 46(1): 59-66.
24. Hutchinson B, Forwell SJ, Bennett S, Brown T, Karpatkin H, Miller D. Toward a consensus on rehabilitation outcomes in MS: gait and fatigue. Int J MS Care. 2009; 11: 67-78.
25. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler. 1999; 5(4): 244-50.
26. Kragt JJ, van der Linden FA, Nielsen JM, Uitdehaag BM, Polman CH. Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler. 2006; 12(5): 594-8.
27. Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, et al. Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. Ann Neurol. 1997; 42(3): 379–82.
28. Kaufman M, Moyer D, Norton J. The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler. 2000; 6(4):286-90.
29. Johansson S, Ytterberg C, Claesson IM, Lindberg J, Hillert J, Andersson M, et al. High concurrent presence of disability in multiple sclerosis. Associations with perceived health. J Neurol. 2007; 254(6): 767-73.
30. De Groot V, Beckerman H, Uitdehaag BM, de Vet HC, Lankhorst GJ, Polman CH, et al. The usefulness of evaluative outcome measures in patients with multiple sclerosis. Brain. 2006; 129: 2648–59.
31. Einarsson U, Gottberg K, Fredrikson S, von Koch L, Holmqvist LW. Cognitive and motor function in people with multiple sclerosis in Stockholm County. Mult Scler. 2006; 12: 340-53.
32. Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Adv Ther. 2009; 26(12): 1043-57.
33. Sutliff MH. Contribution of impaired mobility to patient burden in multiple sclerosis. Curr Med Res Opin. 2010; 26(1): 109-19.
34. Klevan G, Jacobsen CO, Aarseth JH, Myhr KM, Nyland H, Glad S, et al. Health related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurol Scand 2014; 129(1):21-6.
35. Pugliatti M, Riise T, Nortvedt MW, Carpentras G, Sotgiu MA, Sotgiu S, et al. Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients. J Neurol. 2008; 255(2): 157-62.
36. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999; 22; 53(5): 1098-103.
37. Beckerman H, Kempen JC, Knol DL, Polman CH, Lankhorst GJ, de Groot V. The first 10 years with multiple sclerosis: the longitudinal course of daily functioning. J Rehabil Med. 2013; 45(1): 68-75.
38. Hoogervorst EL, Zwemmer JN, Jelles B, Polman CH, Uitdehaag BM. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler. 2004; 10(5): 569-74.
39. van der Linden FA, Kragt JJ, Klein M, van der Ploeg HM, Polman CH, Uitdehaag BM. Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. J Neurol Neurosurg Psychiatry. 2005; 76(12): 1677-81.